0 item(s)
View cart
You have no items in your shopping cart.
22
Mar
Bordetella parapertussis: Parapertussis Infection and qPCR Detection
Bordetella parapertussis is a Gram-negative respiratory pathogen closely related to Bordetella pertussis, the causative agent of whooping cough. Although often overlooked, it can cause a clinically similar illness known as parapertussis, particularly in young children. Due to overlapping symptoms but distinct microbiological features, accurate identification is essential for surveillance and clinical management.
Bordetella parapertussis is a Gram-negative respiratory pathogen closely related to Bordetella pertussis, the causative agent of whooping cough. Although often overlooked, it can cause a clinically similar illness known as parapertussis, particularly in young children. Due to overlapping symptoms but distinct microbiological features, accurate identification is essential for surveillance and clinical management.
I Microbiological Characteristics
B. parapertussis is an aerobic, Gram-negative coccobacillus. It grows on specialized media such as Bordet-Gengou agar, with optimal growth at 35–37°C.
Compared to B. pertussis, it grows more rapidly, typically forming visible colonies within 2–3 days. Colonies are smooth and pearl-like with regular edges and may produce a characteristic brown pigment, which aids in differentiation.
II Epidemiology
B. parapertussis infections occur worldwide and often follow cyclical outbreaks every 3–5 years. The disease primarily affects infants and young children, especially those aged 2–6 years.
Notably, individuals vaccinated against B. pertussis may still be susceptible, as current pertussis vaccines offer limited cross-protection against B. parapertussis.
III Clinical Manifestations
Parapertussis presents with symptoms similar to classic whooping cough but is generally milder. The disease progression includes:
- Catarrhal stage: Mild cough, runny nose, and cold-like symptoms lasting 1–2 weeks
- Paroxysmal stage: Episodes of coughing may occur, though the classic “whoop” is less common
- Convalescent stage: Gradual recovery with shorter duration compared to pertussis
Despite milder symptoms, infection can still contribute to transmission and requires proper diagnosis.
IV Laboratory Diagnosis
Accurate laboratory diagnosis is critical to distinguish B. parapertussis from B. pertussis:
- Bacterial culture: High specificity but relatively low sensitivity
- Molecular detection (PCR/qPCR): Rapid, sensitive, and capable of differentiating Bordetella species
- Serological testing: Useful in later stages of infection
Probe-based real-time PCR is currently the preferred method for early and precise detection.
V Treatment and Prevention
B. parapertussis is generally susceptible to macrolide antibiotics. Early treatment can shorten the infectious period and reduce transmission.
Currently, there is no specific vaccine for parapertussis. Preventive measures include:
- Maintaining good personal hygiene
- Practicing proper cough etiquette
- Avoiding crowded places during outbreaks
- Prompt medical consultation and isolation of suspected cases
VI Public Health Significance
Due to its clinical similarity to pertussis and lack of vaccine protection, B. parapertussis represents an underrecognized contributor to respiratory infections.
Enhancing awareness among healthcare professionals and improving laboratory diagnostic capacity are essential for effective disease surveillance and control.
qPCR KIT
Related Product
Bordetella parapertussis Probe qPCR Kit
Catalog No.: 15-12230
This probe-based qPCR kit enables rapid and specific detection of Bordetella parapertussis, supporting respiratory pathogen diagnosis and epidemiological surveillance.
View Product →
Biofargo team
